Mynd.ai Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 20-F
Rhea-AI Summary
Mynd.ai (NYSE American: MYND) received a NYSE American notice on May 18, 2026 for not timely filing its Form 20-F for year ended December 31, 2025.
The company has an Initial Cure Period of six months from May 15, 2026, and ADS trading continues while it works to complete the filing.
Positive
- Six-month Initial Cure Period from May 15, 2026 to regain compliance
- Potential additional cure period of up to six more months at NYSE discretion
- American Depositary Shares continue trading on NYSE American during cure period
- Company working with advisors and auditors to complete Form 20-F
Negative
- Non-compliance with NYSE American continued listing requirements due to late Form 20-F
- Risk of suspension and delisting if compliance not regained within cure periods
- Form 20-F delay tied to unresolved accounting judgments and disclosures
- No assurance company will regain compliance with all NYSE American standards
Key Figures
Previous AI Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 24 | Token airdrop news | Positive | +7.5% | AI-linked token airdrop for shareholders via Q101 Foundation partnership. |
| Dec 15 | AI workplace solution | Positive | +3.1% | Promethean-MAXHUB agreement launching Microsoft Teams-certified solution. |
| Dec 02 | Distribution agreements | Positive | -6.2% | New TD SYNNEX deal and Midwich expansion to broaden U.S. GTM reach. |
| Nov 17 | AI integration launch | Positive | +3.5% | Planned launch of Augment Me AI integration in Explain Everything. |
| Nov 10 | AI strategy partnership | Positive | -7.0% | Strategic relationship with Augment Me for AI-powered learning tools. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-tagged news has produced mixed reactions: several positive stock moves on strategic AI partnerships and product launches, but also notable selloffs, indicating no consistent pattern of market response.
Across recent AI-tagged announcements, Mynd.ai highlighted Promethean’s AI partnerships, integrations, and distribution agreements. Events on Nov 10, 2025, Nov 17, 2025, and Dec 15, 2025 focused on Augment Me and MAXHUB collaborations, generally drawing positive but variable price moves. Others, like the Dec 2, 2025 distribution agreements, saw negative reactions despite strategic positioning. Compared with these growth-oriented AI updates, today’s NYSE American late-filing notice introduces a regulatory and reporting-risk angle rather than an expansion milestone.
Key Terms
form 20-f regulatory
nyse american regulatory
form 12b-25 regulatory
u.s. securities and exchange commission regulatory
continued listing requirements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Notice was issued under Section 1007 of the NYSE American Company Guide, which governs late filings with the SEC. Under this rule, the Company has a six-month period from the filing due date of May 15, 2026 (the "Initial Cure Period") to file the Form 20-F and regain compliance. If the Company does not regain compliance within the Initial Cure Period, the NYSE American may, in its sole discretion, grant an additional period of up to six months (the "Additional Cure Period"), or may determine to commence suspension and delisting procedures.
As disclosed in the Form 12b-25 filed by the Company on April 30, 2026, the Company was unable, without unreasonable effort or expense, to file the Form 20-F as a result of delays in reaching conclusions on certain accounting judgments and disclosures required to be included in its financial statements for the fiscal year ending December 31, 2025. The Company is working diligently with its advisors and auditors to complete the Form 20-F and intends to file within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable NYSE American listing standards.
The Notice has no immediate impact on the listing of the Company's American Depositary Shares, which will continue to trade on the NYSE American, subject to the Company's compliance with other continued listing requirements.
About Mynd.ai, Inc.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words "plan," "will," "believe," "anticipate," "doubt," "expect," "intend," and similar terms and phrases are used in this press release to identify forward-looking statements, including statements regarding the Company's ability to file its Form 20-F. Actual results may differ materially from the results anticipated by the Company's forward-looking statements due to certain risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's filings with the Securities and Exchange Commission. Given these risks, uncertainties, and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements, even if new information becomes available in the future.
View original content:https://www.prnewswire.com/news-releases/myndai-receives-notice-from-nyse-american-regarding-late-filing-of-annual-report-on-form-20-f-302780434.html
SOURCE Mynd.ai